ACAD vs MSFT: Which Stock is Better?
Side-by-side comparison of Acadia Pharmaceuticals Inc and Microsoft Corp in 2026
ACAD
Acadia Pharmaceuticals Inc
$26.29
MSFT
Microsoft Corp
$454.79
Key Metrics Comparison
| Metric | ACAD | MSFT | Winner |
|---|---|---|---|
| Market Cap | $4.45B | $3.38T | MSFT |
| P/E Ratio | 16.96 | 36.30 | ACAD |
| EPS (TTM) | $1.55 | $13.70 | MSFT |
| Revenue Growth | 0.1% | 14.9% | MSFT |
| Gross Margin | 59.0% | 68.8% | MSFT |
Analyze ACAD
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACAD or MSFT a better investment?
Comparing ACAD and MSFT: Acadia Pharmaceuticals Inc has a market cap of $4.45B while Microsoft Corp has $3.38T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACAD and MSFT?
ACAD (Acadia Pharmaceuticals Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACAD or MSFT?
Based on P/E ratios, ACAD trades at a lower multiple (17.0x vs 36.3x).
Which is growing faster: ACAD or MSFT?
MSFT has higher revenue growth at 14.9% vs 0.1% for ACAD.
Which company is more profitable: ACAD or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to 59.0% for ACAD.
Which is the larger company: ACAD or MSFT?
Microsoft Corp (MSFT) is larger with a market cap of $3.38T compared to $4.45B for ACAD.
Should I buy ACAD or MSFT in 2026?
Both ACAD and MSFT have investment merit. ACAD trades at $26.29 while MSFT trades at $454.79. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACAD and MSFT stock?
Key differences: Market Cap ($4.45B vs $3.38T), P/E Ratio (17.0x vs 36.3x), Revenue Growth (0.1% vs 14.9%), Gross Margin (59.0% vs 68.8%).